Intracoronary injection of adenosine before reperfusion in patients with ST-segment elevation myocardial infarction: A randomized controlled clinical trial

International Journal of Cardiology

Volumn 177, Issue 3, 2014, Pages 935-941

  Garcia Dorado, David ^a   García Del Blanco, Bruno ^a   Otaegui, Imanol ^a   Rodríguez Palomares, José ^a   Pineda, Victor ^b   Gimeno, Federico ^c   Ruiz Salmerón, Rafael ^d   Elizaga, Jaime ^e   Evangelista, Arturo ^a   Fernandez Avilés, Francisco ^e   San Román, Alberto ^c   Ferreira González, Ignacio ^a,f  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^e HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^f CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

Author keywords

Adenosine; Infarct remodeling; Infarct size; Reperfusion injury

Indexed keywords

ADENOSINE; CREATINE KINASE MB; PLACEBO;

ADULT; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR PARAMETERS; COMPLETE HEART BLOCK; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SAFETY; FEMALE; FOLLOW UP; GENERAL PATHOLOGICAL PARAMETERS; GUIDE WIRE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART VENTRICLE REMODELING; HUMAN; INFARCT SIZE; INTRACORONARY DRUG ADMINISTRATION; ISCHEMIA TIME; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TIMI FLOW GRADE; TREND STUDY;

EID: 84919973523     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.09.203     Document Type: Article

References (30)

1. H.D. White, and D.P. Chew Acute myocardial infarction Lancet 372 9638 2008 570 584
2. P.W. Armstrong, A.H. Gershlick, P. Goldstein, R. Wilcox, T. Danays, and Y. Lambert Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction N Engl J Med 368 15 2013 1379 1387
3. C.J. Terkelsen, J.T. Sorensen, M. Maeng, L.O. Jensen, H.H. Tilsted, and S. Trautner System delay and mortality among patients with STEMI treated with primary percutaneous coronary intervention JAMA 304 7 2010 763 771
4. C.J. Terkelsen, L.O. Jensen, H.H. Tilsted, S. Trautner, S.P. Johnsen, and W. Vach Health care system delay and heart failure in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: follow-up of population-based medical registry data Ann Intern Med 155 6 2011 361 367
5. D.J. Hausenloy, B.H. Erik, G. Condorelli, P. Ferdinandy, D. Garcia-Dorado, and G. Heusch Translating cardioprotection for patient benefit: position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology Cardiovasc Res 98 1 2013 7 27
6. M.B. Forman, G.W. Stone, and E.K. Jackson Role of adenosine as adjunctive therapy in acute myocardial infarction Cardiovasc Drug Rev 24 2 2006 116 147
7. Z. Yang, W. Sun, and K. Hu Molecular mechanism underlying adenosine receptor-mediated mitochondrial targeting of protein kinase C Biochim Biophys Acta 1823 4 2012 950 958
8. H. Kin, A.J. Zatta, M.T. Lofye, B.S. Amerson, M.E. Halkos, and F. Kerendi Postconditioning reduces infarct size via adenosine receptor activation by endogenous adenosine Cardiovasc Res 67 1 2005 124 133
9. Z. Xu, S.S. Park, R.A. Mueller, R.C. Bagnell, C. Patterson, and P.G. Boysen Adenosine produces nitric oxide and prevents mitochondrial oxidant damage in rat cardiomyocytes Cardiovasc Res 65 4 2005 803 812
10. M. Marzilli, E. Orsini, P. Marraccini, and R. Testa Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction Circulation 101 18 2000 2154 2159
11. W. Desmet, J. Bogaert, C. Dubois, P. Sinnaeve, T. Adriaenssens, and C. Pappas High-dose intracoronary adenosine for myocardial salvage in patients with acute ST-segment elevation myocardial infarction Eur Heart J 32 7 2011 867 877
12. G. Niccoli, S. Rigattieri, M.R. De Vita, M. Valgimigli, P. Corvo, and F. Fabbiocchi Open-label, randomized, placebo-controlled evaluation of intracoronary adenosine or nitroprusside after thrombus aspiration during primary percutaneous coronary intervention for the prevention of microvascular obstruction in acute myocardial infarction: the REOPEN-AMI study (Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction) JACC Cardiovasc Interv 6 6 2013 580 589
13. K.W. Mahaffey, J.A. Puma, N.A. Barbagelata, M.F. DiCarli, M.A. Leesar, and K.F. Browne Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial J Am Coll Cardiol 34 6 1999 1711 1720
14. A.M. Ross, R.J. Gibbons, G.W. Stone, R.A. Kloner, and R.W. Alexander A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II) J Am Coll Cardiol 45 11 2005 1775 1780
15. R.A. Kloner, M.B. Forman, R.J. Gibbons, A.M. Ross, R.W. Alexander, and G.W. Stone Impact of time to therapy and reperfusion modality on the efficacy of adenosine in acute myocardial infarction: the AMISTAD-2 trial Eur Heart J 27 20 2006 2400 2405
16. M. Grygier, A. Araszkiewicz, M. Lesiak, M. Janus, J. Kowal, and W. Skorupski New method of intracoronary adenosine injection to prevent microvascular reperfusion injury in patients with acute myocardial infarction undergoing percutaneous coronary intervention Am J Cardiol 107 8 2011 1131 1135
17. D. Garcia-Dorado, M. Ruiz-Meana, and H.M. Piper Lethal reperfusion injury in acute myocardial infarction: facts and unresolved issues Cardiovasc Res 83 2 2009 165 168
18. A.E. Denktas, H.V. Anderson, J. McCarthy, and R.W. Smalling Total ischemic time: the correct focus of attention for optimal ST-segment elevation myocardial infarction care JACC Cardiovasc Interv 4 6 2011 599 604
19. G.W. Stone, S.R. Dixon, C.L. Grines, D.A. Cox, J.G. Webb, and B.R. Brodie Predictors of infarct size after primary coronary angioplasty in acute myocardial infarction from pooled analysis from four contemporary trials Am J Cardiol 100 9 2007 1370 1375
20. G.A. Lamas, M.A. Pfeffer, and E. Braunwald Patency of the infarct-related coronary artery and ventricular geometry Am J Cardiol 68 14 1991 41D 51D
21. G. Takemura, M. Nakagawa, H. Kanamori, S. Minatoguchi, and H. Fujiwara Benefits of reperfusion beyond infarct size limitation Cardiovasc Res 83 2 2009 269 276
22. R.A. Kloner, and H. Hwang New insights into the open artery hypothesis Circ Res 103 1 2008 1 3
23. M. Ruiz-Meana, J. Inserte, C. Fernandez-Sanz, V. Hernando, E. Miro-Casas, and I. Barba The role of mitochondrial permeability transition in reperfusion-induced cardiomyocyte death depends on the duration of ischemia Basic Res Cardiol 106 6 2011 1259 1268
24. X.M. Yang, Y. Liu, L. Cui, X. Yang, Y. Liu, and N. Tandon Platelet P2Y(1)(2) blockers confer direct postconditioning-like protection in reperfused rabbit hearts J Cardiovasc Pharmacol Ther 18 3 2013 251 262
25. X.M. Yang, L. Cui, A. Alhammouri, J.M. Downey, and M.V. Cohen Triple therapy greatly increases myocardial salvage during ischemia/reperfusion in the in situ rat heart Cardiovasc Drugs Ther 27 5 2013 403 412
26. D. Garcia-Dorado, J. Oliveras, J. Gili, E. Sanz, F. Perez-Villa, and J. Barrabes Analysis of myocardial oedema by magnetic resonance imaging early after coronary artery occlusion with or without reperfusion Cardiovasc Res 27 8 1993 1462 1469
27. P. Croisille, H.W. Kim, and R.J. Kim Controversies in cardiovascular MR imaging: T2-weighted imaging should not be used to delineate the area at risk in ischemic myocardial injury Radiology 265 1 2012 12 22
28. F. Thuny, O. Lairez, F. Roubille, N. Mewton, G. Rioufol, and C. Sportouch Post-conditioning reduces infarct size and edema in patients with ST-segment elevation myocardial infarction J Am Coll Cardiol 59 24 2012 2175 2181
29. L.F. Robbers, E.S. Eerenberg, P.F. Teunissen, M.F. Jansen, M.R. Hollander, and A.J. Horrevoets Magnetic resonance imaging-defined areas of microvascular obstruction after acute myocardial infarction represent microvascular destruction and haemorrhage Eur Heart J 34 30 2013 2346 2353
30. A. Lombardo, G. Niccoli, L. Natale, A. Bernardini, N. Cosentino, and L. Bonomo Impact of microvascular obstruction and infarct size on left ventricular remodeling in reperfused myocardial infarction: a contrast-enhanced cardiac magnetic resonance imaging study Int J Cardiovasc Imaging 28 4 2012 835 842